|
|
Office Locations:
|
885 Third Avenue, 24th Floor
New York, NY 10022
Phone: 646-585-5434
| | |
|
|
|
- Expansion
- Late
- Middle Market
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Petrichor Healthcare Capital Management partners with world-class healthcare managers and businesses to provide customized investment structures and support. The Petrichor team of investment professionals comes from highly-regarded financial institutions including OrbiMed Advisors and Fortress Investment Group. Collectively, the team has completed over 80 investments representing more than $5 billion in invested capital and has held over 30 board seats. Petrichor makes structured equity and credit investments across the global healthcare sector, with a focus on Biopharmaceuticals, Medical Technology, and Diagnostics. The firm provides flexible and tailored investment solutions for late and commercial stage companies. Petrichor works with both public and private companies to support their long-term growth efforts and have experience underwriting product acquisitions, product development activities, and commercial launches or expansions, among other types of situations.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
